Thomas DesRosier, Chief Legal Officer and EVP at Seres Therapeutics, Inc. (MCRB), sold 878 shares at $0.54 ($474) on 2024-11-18, disclosed to the SEC on 2024-11-19.
Scheduled sale ($474) by Chief Legal Officer and EVP under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MCRB | SELL | 2026-02-18 | $661 | — | Filing → |
| MCRB | SELL | 2025-11-18 | $1K | — | Filing → |
| MCRB | SELL | 2025-08-19 | $1K | — | Filing → |